Michael Neely, MD
Dr. Neely is the director of the University of Southern California Laboratory of Applied Pharmacokinetics, which has been at the forefront of nonparametric population pharmacokinetic modeling techniques and dose optimization for individual patients for over 35 years.
He is an Associate Professor of Pediatrics, Clinical Scholar at the University of Southern California (USC) and at Children’s Hospital Los Angeles. His research and clinical interests are in pediatric clinical pharmacometrics, including population pharmacokinetic and pharmacodynamic modeling, pharmacogenomics, simulation, and most importantly, use of models to optimize therapy for individual patients. He has a Master of Science degree in Clinical and Biomedical Investigations from USC, with a focus on applied Bayesian approaches to clinical trial design and pharmacokinetic modeling.
He is a member of the United States Food and Drug Administration Anti-infective Drug Advisory Committee and is board-certified in pediatrics and pediatric infectious diseases as well as a Fellow of the American College of Clinical Pharmacology. He completed a four-year NIH career development award, and is the Principle Investigator for two R01 awards from the NIH totaling over 6 million dollars. These took over 5 years to develop and involve the application of pharmacometric techniques to anti-infective therapy in populations and individual patients.
Dr. Neely has over 50 publications in peer-reviewed journals, and is invited to give talks and workshops on dose individualization and optimization worldwide.